(相关资料图)
6月30日北向资金增持28.85万股赛生药业（06600.HK）。近5个交易日中，获南向资金增持的有3天，累计净增持77.7万股。近20个交易日中，获南向资金增持的有14天，累计净增持519.0万股。截至目前，南向资金持有赛生药业（06600.HK）1.13亿股，占公司已发行普通股的18.26%。
赛生药业控股有限公司是一家主要从事上市产品组合及其重点治疗领域（包括肿瘤及重症感染）在研产品开发与销售业务的中国生物制药公司。该公司主要销售自有产品日达仙，销售授权引入产品以及代表业务合作伙伴在中国销售推广产品。
2023-07-01
2023-07-01
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-30
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-29
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-28
2023-06-27
2023-06-27
2023-06-27
2023-06-27
2023-06-27
2023-06-27
2023-06-27